Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析

◆英語タイトル:Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review
◆商品コード:DATA904C2523
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Laboratoires Pierre Fabre SA – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs and natural health products. The company’s products address the full spectrum of health care needs from pathologies such as cancer or atopical dermatitis to rare diseases including pediatric hemangioma, family hygiene to skin, hair and scalp care; and from day-to-day illnesses. Pierre Fabre sells and markets its products under various brands which include Derma, Galenic Klorane, Avene, Ducray, Rene Furterer, and others. Pierre Fabre is headquartered in Ile-de-France, France.

Laboratoires Pierre Fabre SA Key Recent Developments

Jun 15,2018: Feelcaps, to promote physical activity among cancer patients
May 04,2018: Pierre Fabre Appoints Eric Ducournau As New Chief Executive Officer
Jan 09,2018: Pierre Fabre Dermo-Cosmetics and MEME announce the signing of a partnership to support patients suffering from cancer
Oct 10,2017: Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates
Aug 22,2017: Cellectar Biosciences Announces Significant PDC Platform Advancement; Demonstrates Potential to Improve Therapeutic Window

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Laboratoires Pierre Fabre SA – Key Facts 6
Laboratoires Pierre Fabre SA – Key Employees 7
Laboratoires Pierre Fabre SA – Key Employee Biographies 8
Laboratoires Pierre Fabre SA – Major Products and Services 9
Laboratoires Pierre Fabre SA – History 10
Laboratoires Pierre Fabre SA – Company Statement 13
Laboratoires Pierre Fabre SA – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Affiliate 17
Section 2 – Company Analysis 18
Company Overview 18
Laboratoires Pierre Fabre SA – Business Description 19
Business Segment: Dermo-Cosmetics 19
Overview 19
Business Segment: Dermo-Cosmetics 19
Performance 19
Business Segment: Other Activities 19
Performance 19
Business Segment: Pharmaceuticals 19
Overview 19
Performance 20
Geographical Segment: France 20
Performance 20
Geographical Segment: International 20
Performance 20
Laboratoires Pierre Fabre SA – Corporate Strategy 21
Laboratoires Pierre Fabre SA – SWOT Analysis 22
SWOT Analysis – Overview 22
Laboratoires Pierre Fabre SA – Strengths 22
Laboratoires Pierre Fabre SA – Weaknesses 23
Laboratoires Pierre Fabre SA – Opportunities 24
Laboratoires Pierre Fabre SA – Threats 25
Laboratoires Pierre Fabre SA – Key Competitors 26
Section 3 – Company’s Lifesciences Financial Deals and Alliances 27
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Laboratoires Pierre Fabre SA, Recent Deals Summary 29
Section 4 – Company’s Recent Developments 30
Jun 15, 2018: Feelcaps, to promote physical activity among cancer patients 30
Jan 09, 2018: Pierre Fabre Dermo-Cosmetics and MEME announce the signing of a partnership to support patients suffering from cancer 31
Oct 10, 2017: Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates 32
Aug 22, 2017: Cellectar Biosciences Announces Significant PDC Platform Advancement; Demonstrates Potential to Improve Therapeutic Window 33
Mar 23, 2017: PIERRE FABRE signs a partnership with biotech company SETUBIO as part of the Nature Open Library program 34
Section 5 – Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Laboratoires Pierre Fabre SA, Key Facts 6
Laboratoires Pierre Fabre SA, Key Employees 7
Laboratoires Pierre Fabre SA, Key Employee Biographies 8
Laboratoires Pierre Fabre SA, Major Products and Services 9
Laboratoires Pierre Fabre SA, History 10
Laboratoires Pierre Fabre SA, Other Locations 14
Laboratoires Pierre Fabre SA, Subsidiaries 14
Laboratoires Pierre Fabre SA, Affiliate 17
Laboratoires Pierre Fabre SA, Key Competitors 26
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Laboratoires Pierre Fabre SA, Recent Deals Summary 29

List of Figures
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Belk Inc:企業の戦略・SWOT・財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • UbiVac LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiVac LLC (UbiVac) is a clinical stage immuno-oncology companythat offers immunotherapeutic products. The company offers research and development of therapeutic vaccines for the treatment of cancer and infectious diseases. Its pipeline product includes DPV-001, a DC-targeted complex vaccine …
  • Hanesbrands Inc.:企業の戦略・SWOT・財務情報
    Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report Summary Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Okamoto Industries, Inc.:企業の戦略・SWOT・財務情報
    Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fortress Investment Group LLC:企業のM&A・事業提携・投資動向
    Fortress Investment Group LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fortress Investment Group LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • IMPAC Mortgage Holdings Inc (IMH):企業の財務・戦略的SWOT分析
    IMPAC Mortgage Holdings Inc (IMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • MediaTek Inc.:企業の戦略・SWOT・財務情報
    MediaTek Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaTek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報
    Summary La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and …
  • SARIA AS GmbH & Co KG:企業の戦略的SWOT分析
    SARIA AS GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cavion LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cavion LLC (Cavion), formerly Tau Therapeutics LLC is a clinical stage pharmaceutical company that develops modulators and drugs. The company researches and develops T-type calcium channel (Cav3) inhibitors for the treatment of neurologic and oncologic diseases. It provides pipeline products …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CertainTeed Corp:企業の戦略的SWOT分析
    CertainTeed Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Campbell Soup Co (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Co (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • FutureFuel Corp (FF):企業の財務・戦略的SWOT分析
    FutureFuel Corp (FF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆